– Ongoing analysis of interim data from the Phase 2 study of ABP-450 in chronic migraine, which did not achieve its primary or secondary endpoints – – Evaluating next-steps across the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results